ArticleDermatologie (Heidelberg, Germany)2026
[Systemic pruritus: focus on hematological, nephrogenic, and hepatobiliary etiologies].
Article in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic pruritus refers to a chronic, generalized sensation of itching in the absence of primary cutaneous lesions. It may represent an important clinical manifestation of underlying internal disease and is particularly associated with hematologic, nephrologic, and hepatobiliary disorders, often displaying characteristic clinical features. In some cases, pruritus precedes the diagnosis of the underlying condition by months or even years and may therefore serve as an early indicator of a hematologic malignancy or cholestatic liver disease. More commonly, however, it occurs concurrently with the diagnosis of the underlying disorder. The onset of systemic pruritus after the diagnosis has been established is frequently therapy-related or may indicate recurrence of the underlying disease. Management primarily focuses on treatment of the underlying condition. In addition, several symptomatic therapeutic approaches are available to alleviate the associated sensory discomfort. A thorough understanding of the pathophysiology and treatment of systemic pruritus is therefore of considerable clinical importance in general medicine, internal medicine, and dermatology.
Indexed as
Identifiers
42301496What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.